Chondroitin Sulphate and Glucosamine Use Depend on Nonsteroidal Anti-inflammatory Drug Use to Modify the Risk for Colorectal Cancer.
Gemma Ibañez-SanzElisabet GuinóRosa MorrosMaría Ángeles Quijada-ManuittLuisa Carmen de la Peña-NegroVictor MorenoPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Chondroitin sulphate or glucosamine may contribute to the protective effect of NSAID use in colorectal cancer.
Keyphrases